Biomedicines manufacturing facility
In Nantong, China, Givaudan’s Phase 2 liquid flavours production facility is now at commissioning stage.
Our scope on this 6,500sqm Class A & C development includes engineering, procurement, construction management and commissioning.
This is one of a number of significant developments now coming to completion in Asia. Having entered this market in 2006, we have delivered complex projects from the outset and the Asian operations have gone from strength to strength, with our business units in China, Singapore and India all delivering solid growth.
Executing full EPCM projects safely, on time, and within cost and quality expectations, we have gained significant experience with a multinational client base including Merck, Boehringer Ingelheim, Givaudan, GSK and many others.
Asia Managing Director, Derek Mowlds has a very positive outlook for sustainable growth in the coming years, “Our teams in China, Singapore and India have performed very well in 2018. With strong order books and prospects, we are looking good for 2019.”
Contact our team in Asia